Skip to main content

Wyeth-Ayerst Subscribes to LifeSpan s GPCR Database

NEW YORK, Nov. 13 — LifeSpan BioSciences announced on Tuesday that Wyeth-Ayerst Laboratories, a division of American Home Products Corporation, will subscribe to its G protein-coupled receptor database. 

The deal represents the seventh pharmaceutical company to subscribe to the database, LifeSpan said.

Under the terms of the arrangement, Wyeth will have access to LifeSpan’s relational database, which includes expression and localization information for hundreds of GPCRs in normal and diseased tissues combined with thousands of digital images and sequences. 

LifeSpan built the database by combining public DNA and protein-sequence data with the company’s own immunohistochemistry work.  

Further financial details of the contract were not disclosed.

LifeSpan, based in Seattle, is a privately held genomics company specializing in molecular pathology. A company executive said in a statement that LifeSpan is currently developing new databases of other receptor families.

The firm has secured four other subscribers this year for this database.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.